Want to join the conversation?
$SYY 4Q15 PR: Case volume for the company's Broadline operations grew 3.6% during the quarter and approx. 3.2% excluding acquisitions. Case volume for Broadline and SYGMA operations combined grew 2.2% and approx. 1.9% excluding acquisitions.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?